CAG25 treatment significantly facilitated the formation of ATP2A1 exon 22, DMD exon 78 and BIN1 exon 11 inclusions in all the DM1 cell lines (Fig. 6d,e and Supplementary Fig. S11a). The gene discussed is ATP2A1; the disease is myotonic dystrophy type 1.